Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

32.4%

% of IHE's 38 holdings also in PPH

50.0%

% of PPH's 27 holdings also in IHE

Overlap by Weight
Sector Drift (IHE minus PPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in IHE
Weight
in PPH
Overlap
ELI LILLY & CO 20.4% 12.4% 12.4%
JOHNSON & JOHNSON 21.2% 6.4% 6.4%
BRISTOL-MYERS SQUIBB CO 5.5% 5.7% 5.5%
ZOETIS INC 4.5% 4.7% 4.5%
MERCK & CO. INC. 4.2% 5.0% 4.2%

Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to PPH
JOHNSON & JOHNSON 14.8%
ELI LILLY & CO 8.0%
ROYALTY PHARMA PLC CLASS A 4.0%
CATALENT INC 3.5%
INTRA-CELLULAR THERAPIES INC 3.4%
VIATRIS, INC. 3.1%
CORCEPT THERAPEUTICS INC 2.1%
JAZZ PHARMACEUTICALS PLC 2.0%
ELANCO ANIMAL HEALTH, INC. 1.9%
PRESTIGE BRANDS HOLDINGS INC 1.7%
IHE Underweight Relative to PPH
NOVO-NORDISK A/S-SPONS ADR -8.1%
ABBVIE INC -5.9%
MCKESSON CORP -5.6%
AMERISOURCEBERGEN CORP -4.9%
NOVARTIS AG-ADR -4.7%
ASTRAZENECA PLC-SPONS ADR -4.6%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS -4.5%
SANOFI-AVENTIS-ADR -4.0%
GLAXOSMITHKLINE PLC-SPON ADR -3.9%
TEVA PHARMACEUTICAL-SP ADR -3.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY